MEET OUR TEAM
XQ is the Founder and Managing Partner of Esco Ventures, the corporate venture and incubation arm of Esco Group.
Senior Director of Biology
Dr. Huang received his Ph.D. from the University of Texas Southwestern Medical Center. He completed his post-doctoral training in the laboratory of Prof. Tom Maniatis at Harvard University.
Mark Kay is an acknowledged leader in the field of gene therapy and is a leading researcher in both viral and non-viral gene transfer vector systems.
Vice President, Discovery
Ronne obtained his Ph.D. in Biological Sciences from the National University of Singapore.
Elan Ezickson joined the board in 2019. He brings his extensive strategic, biopharmaceutical, operational, and capital formation expertise to Carmine Therapeutics.
Director, Scientific & Business Operations
Tenzin obtained his Ph.D. in Molecular Pharmacology from New York University Medical Center.
Jianzhu Chen is a Professor of Biology at the Koch Institute for Integrative Cancer Research and at the Massachusetts Institute of Technology (MIT) Department of Biology.